Should we offer routine breast cancer screening with mammography

American Family Physician

Volumn 68, Issue 2, 2003, Pages 260-262

  David, Sean P ^a,b  

^a BROWN UNIVERSITY   (United States)

^b BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; CANCER MORTALITY; CANCER SCREENING; CANCER SURVIVAL; CLINICAL TRIAL; COCHRANE LIBRARY; EVIDENCE BASED MEDICINE; FEMALE; HUMAN; MAMMOGRAPHY; MORBIDITY; PRACTICE GUIDELINE; SHORT SURVEY;

BREAST NEOPLASMS; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED;

EID: 0042847145     PISSN: 0002838X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (17)

1. Olsen O, Gotzsche PC. Screening for breast cancer with mammography. Cochrane Database Syst Rev, 2001:CD001877.
2. Humphrey LL, Helfand M, Chan BK, Woolf SH. Breast cancer screening: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med, 2002;137:347-60.
3. Tabar L, Fagerberg G, Duffy SW, Day NE. The Swedish two county trial of mammographic screening for breast cancer: recent results and calculation of benefit. J Epidemiol Community Health, 1989;43:107-14.
4. Nystrom L, Andersson I, Bjurstam N, Frisell J, Nordenskjold B, Rutqvist LE. Long-term effects of mammography screening: updated overview of the Swedish randomised trials. Lancet, 2002;359:909-19.
5. Humphrey L, Chan BK, Detlefsen S, Helfand M. Screening for breast cancer. Systematic Evidence Review no. 15. Rockville, Md.: Agency for Healthcare Research and Quality, 2002.
6. Hennekens CH, Buring JE, Mayrent SL. Case-control studies. In: Epidemiology in medicine. Boston: Little, Brown, 1987:147-8.
7. Shapiro S. The status of breast cancer screening: a quarter of a century of research. World J Surg, 1989;13:9-18.
8. Jaeschke R, Guyatt GH, Sackett DL. Users' guides to the medical literature. III. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients? The Evidence-Based Medicine Working Group. JAMA, 1994;271:703-7.
9. Wilson RE, Donegan WL, Mettlin C, Natarajan N, Smart CR, Murphy GP. The 1982 national survey of carcinoma of the breast in the United States by the American College of Surgeons. Surg Gynecol Obstet, 1984;159:309-18.
10. Lindley C, Vasa S, Sawyer WT, Winer EP. Quality of life and preferences for treatment following systemic adjuvant therapy for early-stage breast cancer. J Clin Oncol, 1998;16:1380-7.
11. Tabar L, Chen HH, Duffy SW, Krusemo UB. Primary and adjuvant therapy, prognostic factors and survival in 1053 breast cancers diagnosed in a trial of mammography screening. Jpn J Clin Oncol, 1999;29:608-16.
12. Colditz GA, Hoaglin DC, Berkey CS. Cancer incidence and mortality: the priority of screening frequency and population coverage. Milbank Q, 1997;75:147-73.
13. Centers for Disease Control and Prevention. Cancer facts & figures 2002. Accessed May 2003 at: www.cancer.org/downloads/STT/CancerFacts&Figures2002TM.pdf.
14. Peto R, Boreham J, Clarke M, Davies C, Beral V. UK and USA breast cancer deaths down 25% in year 2000 at ages 20-69 years. Lancet, 2000;355:1822.
15. Peto R. Mortality from breast cancer in UK has decreased suddenly. BMJ, 1998;317:476-7.
16. Moller P, Borg A, Evans DG, Haites N, Reis MM, Vasen H, et al. Survival in prospectively ascertained familial breast cancer: analysis of a series stratified by tumour characteristics, BRCA mutations and oophorectomy. Int J Cancer, 2002;101:555-9.
17. Swan J, Breen N, Coates RJ, Rimer BK, Lee NC. Progress in cancer screening practices in the United States: results from the 2000 National Health Interview Survey. Cancer, 2003;97:1528-40.